GRMN
67
-4
TGT
45
-4
SWK
50
-5
CVX
43
-3
SIG
44
-3
EXR
57
2
HRB
59
2
SRE
63
2
PVH
60
-4
MTCH
20
-8
RIG
43
-7
STZ
52
-6
STT
64
2
PSA
56
3
HAL
48
-3
GM
74
5
WHR
65
-5
DVN
14
-6
DAL
84
-3
MSI
72
-3
GRMN
67
-4
TGT
45
-4
SWK
50
-5
CVX
43
-3
SIG
44
-3
EXR
57
2
HRB
59
2
SRE
63
2
PVH
60
-4
MTCH
20
-8
RIG
43
-7
STZ
52
-6
STT
64
2
PSA
56
3
HAL
48
-3
GM
74
5
WHR
65
-5
DVN
14
-6
DAL
84
-3
MSI
72
-3
Financhill
Back

Helmerich & Payne Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
37

HP
Helmerich & Payne

Last Price:
33.85
Seasonality Move:
8.25%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
37
Helmerich & Payne (HP) is a Sell

Is Helmerich & Payne a Buy, Sell or Hold?

  • The current Helmerich & Payne [HP] share price is $33.85. The Score for HP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • HP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HP Stock Price Chart

What is Helmerich & Payne's stock price today?

  • The Helmerich & Payne share price today is $33.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HP is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.4 Buy
Relative Strength Index (14 RSI): 45.92 Sell
Chaikin Money Flow: -1329441 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.62 - 35.94) Sell
Bollinger Bands (100): (31.92 - 37.24) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.74 Sell
20-day SMA: 34.67 Sell
50-day SMA: 33.39 Buy
200-day SMA: 36.72 Sell
8-day EMA: 35.03 Sell
20-day EMA: 34.79 Sell
50-day EMA: 34.28 Sell
200-day EMA: 35.87 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Helmerich & Payne Earnings Growth & HP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and an increase next year of $0.09 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Helmerich & Payne Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):